Carregant...
Recurrent Bilateral Strokes in a Patient Treated With Sipuleucel-T for Prostate Cancer
Sipuleucel-T is approved by the US Food and Drug Administration (FDA) for the treatment of castration-resistant prostate cancer (CRPC). Herein, we present a patient with recurrent bilateral embolic stroke who was on sipuleucel-T therapy for CRPC. Laboratory and imaging data didn’t reveal any source...
Guardat en:
| Publicat a: | Cureus |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Cureus
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8137308/ https://ncbi.nlm.nih.gov/pubmed/34036014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.14596 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|